Validity of multiplex-based assays for cytokine measurements in serum and plasma from "non-diseased" subjects: Comparison with ELISA

被引:77
作者
Dossus, Laure [1 ]
Becker, Susen [1 ]
Achaintre, David [2 ]
Kaaks, Rudolf [1 ]
Rinaldi, Sabina [2 ]
机构
[1] German Canc Res Ctr, Div Canc Epidemiol, D-69120 Heidelberg, Germany
[2] Int Agcy Res Canc, F-69372 Lyon 08, France
关键词
Cytokine; ELISA; Multiplex-based assays; Epidemiology; CULTURE SUPERNATANTS; XMAP TECHNOLOGY; IMMUNOASSAY; VALIDATION; INFLAMMATION; CANCER; QUANTITATION; RISK; KITS;
D O I
10.1016/j.jim.2009.09.001
中图分类号
Q5 [生物化学];
学科分类号
070307 [化学生物学];
摘要
Multiplex-based immunoassays (MIA) allow the simultaneous measurement of different cytokines in small sample Volumes, but their applicability in samples from "healthy" subjects, as those participating in large-scale epidemiological studies is not well known. We compared measurements of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), interleukin-1 receptor antagonist (IL-1Ra), C-reactive protein (CRP) and soluble CD40L (sCD40L) obtained by MIA with those obtained by enzyme-linked immunosorbent assays (ELISA) in serum and plasma samples from 36 "healthy" subjects. We observed good correlations between measurements obtained by MIA and ELISA for IL-1Ra, CRP and sCD40L (r > 0.80) but poor correlations for IL-6, TNF-alpha and IL-1 beta (r < 0.40). When comparing MIA plasma and serum measurements, very high correlations were obtained for CRP (r = 0.98) and fairly good correlations for IL-1Ra (r = 0.60). In conclusion, multiplex-based assays can give an accurate estimate of the relative risk in large-scale epidemiological studies but only for cytokines that are present in relatively large concentrations (ng/mL). (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:125 / 132
页数:8
相关论文
共 24 条
[1]
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[2]
Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay [J].
Carson, RT ;
Vignali, DAA .
JOURNAL OF IMMUNOLOGICAL METHODS, 1999, 227 (1-2) :41-52
[3]
Inflammation and cancer [J].
Coussens, LM ;
Werb, Z .
NATURE, 2002, 420 (6917) :860-867
[4]
Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies [J].
de Jager, W ;
Prakken, BJ ;
Bijlsma, JWJ ;
Kuis, W ;
Rijkers, GT .
JOURNAL OF IMMUNOLOGICAL METHODS, 2005, 300 (1-2) :124-135
[5]
The epidemiology of low-grade chronic systemic inflammation and type 2 diabetes [J].
Duncan, Bruce B. ;
Schmidt, Maria Ines .
DIABETES TECHNOLOGY & THERAPEUTICS, 2006, 8 (01) :7-17
[6]
Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: Determinations of a panel of nine cytokines in clinical sample culture supernatants [J].
duPont, NC ;
Wang, KH ;
Wadhwa, PD ;
Culhane, JF ;
Nelson, EL .
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2005, 66 (02) :175-191
[7]
Soluble CD40 ligand measurement inaccuracies attributable to specimen type, processing time, and ELISA method [J].
Halldórsdóttir, AM ;
Stoker, J ;
Porche-Sorbet, R ;
Eby, CS .
CLINICAL CHEMISTRY, 2005, 51 (06) :1054-1057
[8]
Hildesheim A, 2002, CANCER EPIDEM BIOMAR, V11, P1477
[9]
Kellar KL, 2001, CYTOMETRY, V45, P27, DOI 10.1002/1097-0320(20010901)45:1<27::AID-CYTO1141>3.0.CO
[10]
2-I